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Abstract
Background: Infections with different herpes viruses have been associated with cognitive functioning in psychiatric patients
and healthy adults. The aim of this study was to find out whether antibodies to different herpes viruses are prospectively
associated with cognitive functioning in a general adolescent population.
Methods: This study was performed in TRAILS, a large prospective general population cohort (N = 1084, 54% female, mean
age 16.2 years (SD 0.6)). At age 16, immunoglobulin G antibodies against HSV1, HSV2, CMV and EBV were measured next to
high sensitive C-Reactive Protein (hsCRP). Two years later, immediate memory and executive functioning were assessed
using the 15 words task and the self ordered pointing task. Multiple linear regression analysis with bootstrapping was
performed to study the association between viral infections and cognitive function, adjusting for gender, socioeconomic
status, ethnicity, and cannabis use.
Results: Presence of HSV1 antibodies was associated with memory function ((B =20.272, 95% CI =20.556 to 20.016,
p = 0.047)), while the association with executive functioning did not reach statistical significance (B = 0.560, 95% CI is 20.053
to 1.184, p = 0.075). The level of HSV1 antibodies was associated with both memory function (B =20.160, 95% CI =20.280
to 20.039, p = 0.014) and executive functioning (B = 0.296, 95% CI = 0.011 to 0.578, p = 0.046). Other herpes viruses and
hsCRP were not associated with cognitive functioning.
Conclusions: Both presence and level of HSV1 antibodies are prospectively associated with reduced cognitive performance
in a large cohort of adolescents.
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Introduction
Cognitive impairment is an important clinical problem that
accompanies many psychiatric disorders. It has been described in
schizophrenia [1] and in bipolar disorder and unipolar depression,
both during an episode of depression [2] and in a remitted,
euthymic state [3]. In these patients, cognitive impairment is
associated with difficulties in social, occupational, and educational
functioning and with worse treatment outcomes [1,4]. Although
the factors that cause cognitive impairment are largely unknown, it
is suggested that the presence of antibodies to herpes simplex virus
1 (HSV1) may play a role. A recent review summarized several
studies that found that HSV1 antibodies were associated with
impaired immediate memory and executive functioning in patients
with schizophrenia [5]. This association was also found in patients
with bipolar disorder [6,7]. Antibodies to cytomegalovirus (CMV)
were found to be associated with impaired visual search and
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memory function in patients with schizophrenia [8]. Earlier studies
did not find an association between cognitive functioning and
other herpes viruses such as Epstein Barr virus (EBV) and herpes
simplex type 2 (HSV2) [6,9,10].
The presence of viral antibodies indicates exposure to these
viruses in the past. Theoretically, this association between viral
infection and cognitive performance can be explained in two ways.
The first explanation is that viral infection leads to persistent
infection of the central nervous system (CNS). Human herpes
viruses can cause such infections. They have the ability to be latent
in the CNS, where they might be re-activated and induce
neuroinflammation, which is associated with neurological and
psychiatric symptoms [11]. The limbic brain, especially the
hippocampus, is found to have specific affinity for HSV1 latency.
In post mortem brains of patients with herpes encephalitis, HSV1
was found to be present in the limbic system [12]. The limbic
brain, together with the prefrontal cortex, is an important region
for cognitive functioning, involved in working memory [13] as well
as executive functioning [14]. Imaging studies in patients with
schizophrenia showed that cognitive changes as well as psychosis
were associated with hippocampal inflammation [15].
A second explanation is that viral infections affect cognitive
functioning through systemic inflammation, demonstrated by
associations with C-reactive protein (CRP) in elderly [16], in
healthy adults [17], in patients with schizophrenia [18] and in
patients with major depression [19]. This effect is thought to be
caused by vascular damage [20]. The aggregate number of
pathogens with which an individual is infected, referred to as
pathogen burden, was shown to be more strongly associated with
vascular damage than the type of viral agent [21]. A recent study
in schizophrenia patients and healthy controls found that the
amount of herpes viruses that the participants were exposed to was
associated with the reduction of cognitive performance, regardless
of diagnosis [22]. These results suggest that systemic inflammation
could also be the underlying mechanism causing impaired
cognitive functioning.
Thus, psychiatric disorders are often accompanied by cognitive
impairment and cognitive impairment is found to be associated
with viral antibodies in patients with schizophrenia and in patients
with mood disorders. The causal pathway for this association,
however, remains unknown. Viral infections might be associated
with psychopathology, which in turn causes cognitive impairment.
Alternatively, it is possible that viral infections are directly
associated with cognitive impairment, which then may or may
not be followed by a psychiatric disorder. Studies in healthy
individuals are needed to further unravel these pathways. At
present, such studies are scarce and findings are inconsistent. One
study suggested that there is an association between HSV1
infection and cognitive functioning in healthy adults [10], whereas
an earlier study from the same research group in a different sample
did not find such an association [23]. Another study investigated
the association between cognitive functioning and HSV1 antibod-
ies in both schizophrenia patients and healthy controls. An
association was found in the whole group, with no effect of
diagnosis on this association [24]. This suggests that this
association is also present in healthy participants. Previous studies
investigating inflammatory aspects and cognition have mostly been
performed in adults. This has the disadvantage that with
increasing age, inflammatory and vascular problems increase
due to a variety of causes, and it is therefore difficult to study direct
effects of viruses on cognition.
The aim of this study is to investigate whether exposure to
different herpes viruses, reflected in the presence of viral
antibodies, is predictive of cognitive performance, as indicated
by short term memory and executive functioning. Our primary
hypothesis is that antibodies to latent herpes viruses are associated
with cognitive functioning in healthy adolescents. Our secondary
hypothesis is that the pathogen burden, the number of different
viruses, is more strongly associated with cognitive functioning in
healthy adolescents than the exact type of viral agent. We will also
test the potential role of systemic inflammation, as reflected in
levels of high-sensitive CRP (hsCRP), in the association between
viral infection and cognitive function.
We will test our hypotheses in TRAILS, a large prospective
general adolescent population cohort with measurements being
performed every two years, from age 10 onwards. In this study, we
focus on viral antibodies that have been measured at age 16, and
cognitive functioning assessed two years later. Because presence of
viral antibodies was found to be associated with immediate
memory and executive functioning in patients with schizophrenia
and bipolar disorder, we focus on these cognitive domains.
Methods
Study population
The study is part of the TRacking Adolescents’ Individual Lives
Survey (TRAILS), a large prospective population study of 2230
Dutch adolescents from the north of the Netherlands examining
causes and outcomes of physical and mental health from
childhood into adulthood. The survey was approved by the
national ethical committee ‘‘Centrale Commissie Mensgebonden
Onderzoek’’. Written Informed Consent was obtained from
children and their parents or caretakers. A more elaborate
description of the design can be found elsewhere [25]. In short,
all 135 primary schools in the five major municipalities in the
northern Netherlands were asked to participate. Children with
mental retardation, physical incapability or language problems
were excluded. The study started in 2001 with the first wave of
measurements, with four follow up measurements every two years.
During the third assessment wave, a blood sample was obtained
for biomarker analyses (mean age = 16.2, SD=0.6). At the
University Medical Center Groningen, serum was extracted and
stored at 280uC until analysis. During the fourth follow up
assessment, at the age of approximately 18, participants performed
a set of cognitive tasks for neuropsychological evaluation.
Cognitive symptoms
The cognitive tests we selected for this paper give information
about immediate memory and executive functioning, as cognitive
performance in these areas was associated with HSV1 infection in
earlier studies [8,9,26]. The computer version of the Self Ordered
Pointing Test was used to measure executive functioning [27]. In
this task, the participants have to select a picture from several
pictures on the computer screen, which is repeated several times.
The participant is not allowed to select the same picture twice or to
select the same place on the computer screen twice. The task
consists of four parts, with nine or twelve pictures and with
abstract or concrete pictures. The most sensitive outcome measure
of this task is the error score [28]. We have combined the error
scores of the four tasks to get a total error score of this task. To test
immediate memory function, we used the Rey’s Verbal Learning
Test. In this test, participants were asked to memorize 15 words
that are read aloud by the task leader, which is repeated five times.
We used the total amount of words that the participants could
remember at the first three recalls, because previous studies have
found ceiling effects when all five trials were used [29]. Verbal task
instructions were given before each task. To ensure that the
Exposure to HSV1 and Cognitive Functioning in Adolescents
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e101549
adolescents understood these instructions, practice trials were
performed preceding task assessment.
Measurement of antibodies
Infection of the human body by most infectious agents is
associated with the development of persistent immunoglobulin G
(IgG) class antibodies that can be measured in the blood years after
the infection. IgG serum antibodies to different agents of the
Herpes virus family (HSV1, HSV2, CMV and EBV) were
measured using solid-enzyme immunoassay methods [30]. For
each assay, a result was defined as positive or negative based on
comparison with the reactivity of specific antibody standards saved
along with the blood samples. These standards consisted of
samples with predefined levels of reactivity of specific herpes
antigens [31].These analyses provided information on the
presence of the different antibodies as well as on the level of
infectious activity reflected in the levels of the different antibodies.
Presence of antibodies reflects whether the adolescent was ever
exposed to the virus, whereas levels of antibodies reflect the
activity of the virus at age 16.The aggregate number of different
pathogens that the adolescents had antibodies to, was referred to
as pathogen burden [21]. All serological tests were carried out by
standard procedure at the Stanley Laboratory of Developmental
Neurovirology, Baltimore, Maryland.
Measurement of hsCRP
C-reactive protein (CRP) is produced by the liver in reaction to
pro-inflammatory cytokines and is a measurement for systemic
inflammation. High sensitive-CRP (hsCRP) is more sensitive to
small changes in systemic inflammation, since it is detected at
lower values [32]. hsCRP was determined using a immunonephe-
lometric method with a lower detection limit of 0.175 mg/L.
Intra-assay coefficients of variance ranged from 2.1 to 4.4, and
inter-assay coefficients of variation coefficients of variance ranged
from 1.1 to 4.0.
Confounders
Socioeconomic status (SES) was defined by family income,
educational level of the father and the mother, and occupational
level of both parents using the International Standard Classifica-
tion of Occupations [33]. A SES variable was created by averaging
the indicators after standardization. Factor analysis in this
population showed a Crohnbach’s alpha of 0.84 [34]. Affective
symptoms were assessed using the Affective Problems scale of the
Youth Self-Report (13 items, Cronbach’s alpha = 0.75) [35]. The
frequency of cannabis use in the four weeks prior to the cognitive
test was assessed in a self-report questionnaire; answers were
categorized into use of cannabis or no use of cannabis. Adolescents
who had at least one parent born in a non-western country were
identified to estimate ethnicity; this included Turkey, Morocco,
Surinam, Dutch Antilles, Indonesia, Iraq, Iran, Somalia, etc.
Statistical analysis
Because of non-normal distribution of hsCRP, Mann Whitney
U-tests were used to examine the association between hsCRP
values and the presence of viral antibodies. To determine the
association between hsCRP and pathogen burden, Spearman’s
rho was used, because both hsCRP and pathogen burden had a
non-normal distribution. Multiple linear regression analysis was
conducted to evaluate whether hsCRP, the presence and the levels
of viral antibodies, and the pathogen burden were associated with
cognitive functioning two years later. Because of non-normal
distribution of data, we performed bootstrapping analysis in our
regression model. Bootstrapping gets around the problem of non-
normal distribution by estimating the properties of the sampling
distribution from sample data (called bootstrapping samples). The
values of the samples are used to estimate the limits of the 95%
confidence interval of the parameter. An effect is considered
significant when the bootstrap 95%-CI does not include zero [36].
In the multiple regression models, we adjusted for the following
confounders, known to be associated with our predictor (pathogen
burden, viral infections or CRP) and our outcome measure
(cognitive functioning): gender [37–39], socioeconomic status
(SES) [39–41], ethnicity [42,43] and cannabis use [44,45].
Affective symptoms are also associated with cognitive functioning
and inflammatory measurements [46,47]. It is, however, unknown
whether they would be influencing outcomes as a confounder or as
a mediator. Therefore, we repeated analysis with affective
symptoms as a covariate, to perform a sensitivity analysis.
Results
Population Characteristics
The population characteristics are summarized in table 1.
Pathogen Burden is shown in figure 1.
Association between viral antibodies and cognitive
functioning
Table 2 summarizes the association between the presence and
the levels of the different viral antibodies and total error scores on
SOPT. Table 3 summarizes the association between the presence
and the levels of the viral antibodies and immediate memory
scores. The presence of HSV1 antibodies was associated with the
immediate memory score of the 15 words task, but not with the
total error score of SOPT. The level of HSV1 antibodies was
associated with both the 15 words and with the error score of the
SOPT. Both presence and levels of antibodies to the other viruses
were not significantly associated with any of the measures of
cognitive performance. Analyses were repeated with affective
symptoms as covariate, yielding essentially the same results.
Association between Pathogen Burden and cognitive
functioning
The immediate memory score of the 15 words task was not
associated with Pathogen Burden (B=20.058, 95% CI is 20.186
to 0.086, p = 0.425). Likewise, the total error score of the SOPT
was not associated with Pathogen Burden (B=20.468, 95% CI is
20.084 to 0.548, p = 0.145). We repeated the analyses with
affective symptoms as covariate, which gave essentially the same
results.
Inflammation and viral infection
We performed Mann Whitney U tests to assess whether the
presence of viral antibodies was associated with systemic
inflammation, as reflected in levels of hsCRP. The presence of
HSV1 antibodies was significantly associated with hsCRP: the
HSV1 positive group (mean rank 592.79) had significantly higher
levels of hsCRP than the HSV1 negative group (mean rank
523.67) (p = 0.001). Presence of antibodies to other viruses was not
associated with hsCRP levels. Pathogen burden was also associated
with hsCRP (Spearman’s rho= 0.090; p= 0.003).
Association between systemic inflammation and
cognitive functioning
Multiple regression analysis, adjusting for gender, SES, ethnicity
and cannabis use, was performed to test the association between
Exposure to HSV1 and Cognitive Functioning in Adolescents
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the scores on the two different cognitive tasks and the levels of
hsCRP. The immediate memory score of the 15 words task was
not associated with hsCRP levels (B=20.002, 95% CI is 20.024
to 0.015, p = 0.817). Likewise, the total error score of the SOPT
was not associated with the hsCRP levels (B=20.013, 95% CI is
20.052 to 0.018, p = 0.331). We repeated the analyses with
affective symptoms as covariate, which gave essentially the same
results. Thus, hsCRP does not suffice with the conditions to be a
mediator in the relationship between HSV1 antibodies and
cognitive functioning.
Discussion
This is, to our knowledge, the first prospective study examining
the association between viral antibody status and subsequent
cognitive function in a large cohort of healthy adolescents. Our
findings showed an association between the presence and levels of
HSV1 antibodies at age 16 and cognitive function at age 18,
indicated by performance at a short term memory task and an
executive functioning task. There was no association between
cognitive function and CRP, other viruses, or total pathogen
burden.
A major strength of this study is the size of our study population,
enabling an accurate estimation of the temporal association
between viral antibodies and cognitive performance two year
afterwards. A second strength is the fact that we studied cognitive
performance in healthy adolescents; at this young age cognitive
performance is not yet influenced by other factors such as vascular
damage and normal aging. Some limitations of our study need to
be addressed as well. One limitation is the fact that antibody status
does not inform us on the moment in their life at which the
adolescents were exposed to the herpes viruses. Also, viral
antibodies were assessed at age 16, while cognitive function was
measured at age 18. It is likely that virus burden was increased
between age 16 and 18, especially since kissing behavior is an
imported way to get infected with herpes viruses. The prevalence
of the herpes viruses at age 16 in our population was low
compared to findings in adolescents in age group 15–19 from
other countries, with 70% seroprevalence for EBV in the USA
[48], 1.6% for HSV2, 39% for HSV1 in the USA [49], and 35%
for CMV in Germany [50]. Factors associated with EBV
seropositivity include ethnicity, crowdedness, household income,
household education level and health insurance status [48], and
international variability in these factors might contribute to our
low EBV seroprevalence. Nevertheless, this low prevalence
facilitates the testing of differences in cognitive performance in
adolescents that are exposed to the viruses and adolescents that are
not. Another limitation is that cognitive functioning was not
assessed at age 16, making it impossible to calculate an estimate of
cognitive change. Furthermore, a limitation is that most adoles-
cents had no antibodies to pathogens, or only antibodies to one
Figure 1. Pathogen Burden. Distribution of number of pathogens in percentages, present in the adolescent population.
doi:10.1371/journal.pone.0101549.g001
Table 1. Population Characteristics.
General Characteristics % (n)
Age (mean, SD) 16.2 (0.6)
Female 54.0 (585)
SES (Median, IQR) 0.15 (20.4, 0.8)
Dutch Ethnicity 90.4 (980)
Cannabis use 17.7 (192)







SOPT error scores (Median, IQR) 8.0 (6.0, 10.0)
15 words immediate memory (Median, IQR) 9.0 (7.7,10.3)
Numbers are presented as %(N) unless otherwise specified.
IQR = Interquartile range, SES = socio-economic status, hsCRP = high
sensitive C-Reactive Protein, HSV1 = Herpes Simplex Virus 1, HSV2 = Herpes
Simplex Virus 2, EBV = Epstein Barr Virus, CMV = Cytomegalovirus, SOPT = self
ordered pointing task.
doi:10.1371/journal.pone.0101549.t001
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pathogen. This probably makes pathogen burden per se a less
informative measurement in this age group.
We were the first to find a significant association between the
presence and levels of viral antibodies at age 16 and cognitive
performance two years later. The association between HSV1 and
cognitive performance is in line with findings reported by previous
studies using a cross-sectional design [5,10]. Our findings could
mean that the association between antibodies and cognitive
functioning is not a state effect, but that the presence of antibodies
has longer-lasting effects on cognitive functioning. We used
different tasks to test the cognitive domains that were found to
be associated with HSV1 in previous studies [5,7]. The fact that
we found an association in the same cognitive domain as in
previous research with a different task makes the finding more
robust. HSV2, EBV and CMV were not associated with cognitive
functioning in our study, which is in agreement with previous
findings [6,9,10]. In contrast to our findings, one previous study
found CMV antibodies to be associated with cognitive perfor-
mance in patients with schizophrenia [8]. In this study, cognitive
performance was assessed using the Trail Making Task, which
measures attention and task switching. This could be an
explanation for the different findings. In a recent case study, two
adolescent homozygote twin pairs were followed, in which one of
the pair was seropositive for CMV and the other seronegative. In
both pairs, there was no difference in neurocognitive development
between the seropositive and the seronegative twin [51]. Together
with our findings, this suggests that CMV is not predictive for
cognitive performance in adolescents.
We found an association between HSV1 antibodies and
cognitive function in a healthy population, suggesting that this
association is independent of psychopathology. The association
between HSV1 antibodies and cognitive functioning was initially
studied in patients with mental disorders, because schizophrenia
has been shown to be associated with viral infections [52]. In a
systematic review on cognitive functioning in schizophrenia, it was
hypothesized that cognitive impairment could be considered a risk
factor for developing psychopathology [1]. This could mean that
HSV1 infection may lead to the development of psychopathology
via cognitive impairment.
As discussed in the introduction, the association between viral
antibodies and cognitive functioning can be explained by either
local infection of the CNS or systemic inflammation leading to
toxic effects and vascular damage. Our findings do not differen-
tiate between these explanations. It is, however, remarkable that
only presence of HSV1 antibodies was significantly associated with
hsCRP and that the presence and level of only the HSV1
antibodies were predictive for cognitive performance. This is in
line with a recent study in patients with schizophrenia, in which
both high CRP values and HSV1 antibodies predicted cognitive
functioning. This association was most pronounced when both
HSV1 and high CRP levels were present, but an interaction effect
between CRP and HSV1 was not found [53]. The fact that the
level of antibodies to HSV1 was more strongly associated with
cognitive performance than the presence of antibodies to HSV1
fits both theories. The level of HSV1 antibodies can reflect the
activity of the HSV1 virus or the activity of the immune system in
general.
In conclusion, our results suggest that previous HSV1 infection,
as reflected in the presence of HSV1 antibodies, is predictive for
cognitive performance two years later in healthy adolescents. It
would be of interest to replicate this study with more frequent
measurements regarding cognitive functioning and viral status.
Furthermore, herpes related cognitive impairment may also be
predictive of the development of mental disorders, the investiga-
tion of which would need prospective studies with longer follow-up
times. The pathophysiological explanation for the association
between HSV1 infection and activity and cognitive functioning
currently remains unknown. As temporal lobe structures such as
Table 2. Association between the presence and levels of viral antibodies and executive functioning two years later, as measured
by Self Ordered Pointing Task.
Presence of antibodies Levels of antibodies
HSV1 B= 0.554, 95% CI: 20.074 to 1.178, p = 0.078 B= 0.295, 95% CI: 0.008 to 0.576, p=0.045
HSV2 B= 0.158, 95%CI: 21.000 to 1.221, p = 0.785 B= 0.327, 95%CI: 20.317 to 1.098, p = 0.332
EBV B=20.209, 95% CI: 20.746 to 0.386, p = 0.460 B=20.026, 95% CI: 20.467 to 0.410, p = 0.908
CMV B= 0.471, 95% CI: 20.120 to 1.161, p = 0.158 B= 0.155, 95% CI: 20.123 to 20.486, p = 0.324
HSV1 = Herpes Simplex Virus 1, HSV2 = Herpes Simplex Virus 2, EBV = Epstein Barr Virus, CMV = Cytomegalovirus.
Outcomes of multiple regression analyses with bootstrapping, adjusted for gender, SES, ethnicity, and cannabis use.
doi:10.1371/journal.pone.0101549.t002
Table 3. Association between the presence and levels of viral antibodies and immediate memory two years later, as measured by
the immediate recall part of the 15 words task.
Presence of antibodies Levels of antibodies
HSV1 B =20.273, 95%CI:20.522 to 20.015, p=0.046 B=20.160, 95%CI:20.728 to 20.041, p=0.015
HSV2 B =20.541, 95%CI: 21.137 to 0.281, p = 0.208 B=20.224, 95%CI: 20.728 to 0.193, p = 0.330
EBV B =20.052, 95%CI: 20.302 to 0.214, p = 0.701 B=20.098, 95%CI: 20.296 to 0.110, p = 0.356
CMV B=0.149, 95%CI: 20.072 to 0.400, p = 0.234 B= 0.083, 95%CI: 20.026 to 0.198, p = 0.168
HSV1 = Herpes Simplex Virus 1, HSV2 = Herpes Simplex Virus 2, EBV = Epstein Barr Virus, CMV = Cytomegalovirus.
Outcomes of multiple regression analyses with bootstrapping, adjusted for gender, SES, ethnicity, and cannabis use.
doi:10.1371/journal.pone.0101549.t003
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hippocampus are primary hosts for HSV1 in the brain, future
studies could be directed towards assessment of viruses or
inflammation in this region, for example by using molecular
neuro-imaging techniques of the brain.
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